Clinical Trials Browser

Carcinoma, Neuroendocrine × lutetium Lu 177 dotatate × 1 year × Clear all

NCT01876771 2025-08-08

A Trial to Assess the Safety and Effectiveness of Lutetium-177 Octreotate Therapy in Neuroendocrine Tumours

Phase 2 Recruiting

Carcinoma, Neuroendocrine